banner
bibliotecahuvh.bsky.social
@bibliotecahuvh.bsky.social
Biblioteca del Vall d’Hebron Barcelona Hospital Campus
Pinned
Cerqueu els articles dels autors @vallhebroncampus.bsky.social
per la seva especialitat indicant: #hvhebron + etiqueta (per exemple #hvhebron #onco )
I afegiu "Text complet" per llegir els que estan en accés obert (#hvhebron #onco [Text complet])
Etiquetes creades 👇
JAK inhibitor selection in challenging scenarios of myelofibrosis: a review haematologica.org/article/view... #hvhebron #hemat [Text complet]
Early View | Haematologica
haematologica.org
December 5, 2025 at 1:02 PM
Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01 jamanetwork.com/journals/jam... #hvhebron #onco [Text complet]
Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer
This follow-up analysis of the phase 2 HERIZON-BTC-01 trial evaluates the efficacy, patient-reported outcomes, and safety profile of zanidatamab in patients with ERBB2-amplified biliary tract cancer w...
jamanetwork.com
December 5, 2025 at 1:00 PM
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository ('Registry') www.sciencedirect.com/science/arti... #hvhebron #reu
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository (‘Regi...
There is a lack of high-quality data to inform risk-stratified long-term thrombosis prevention strategies in patients with persistently positive antip…
www.sciencedirect.com
December 5, 2025 at 12:57 PM
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer www.nature.com/articles/s41... #hvhebron #onco [Text complet]
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer - npj Genomic Medicine
npj Genomic Medicine - Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
www.nature.com
December 5, 2025 at 12:56 PM
Biomarker Differences in Aneurysmal Subarachnoid Hemorrhage: A Comparative Study of Patients with and Without Delayed CEREBRAL Ischemia link.springer.com/article/10.1... #hvhebron #neuro
Biomarker Differences in Aneurysmal Subarachnoid Hemorrhage: A Comparative Study of Patients with and Without Delayed CEREBRAL Ischemia - Neurocritical Care
Background Delayed cerebral ischemia (DCI) is a major cause of morbidity following aneurysmal subarachnoid hemorrhage (aSAH), yet early prediction remains challenging. This study aimed to identify blo...
link.springer.com
December 5, 2025 at 12:55 PM
Retorno al trabajo post-meniscectomía parcial. ¡No es tan rápido como creemos! www.medigraphic.com/cgi-bin/new/... #hvhebron #cot [Text complet]
Retorno al trabajo post-meniscectomía parcial. ¡No es tan rápido como creemos!
Idioma: Ingles. Referencias bibliográficas: 20 Paginas: 287-291 Archivo PDF: 210.57 Kb.
www.medigraphic.com
December 5, 2025 at 12:52 PM
The European Society of Gynaecological Oncology position statement: promoting inclusive surgical ergonomics in gynecological oncology www.sciencedirect.com/science/arti... #hvhebron #ginonco
The European Society of Gynaecological Oncology position statement: promoting inclusive surgical ergonomics in gynecological oncology
The European Society of Gynaecological Oncology (ESGO) recognizes that poorly designed instruments and operating room environments contribute to muscu…
www.sciencedirect.com
December 5, 2025 at 12:50 PM
Resultados preliminares del tratamiento de la seudoartrosis mediante ondas de choque de alta energía: estudio cuasiexperimental multicéntrico www.sciencedirect.com/science/arti... #hvhebron #mfis
Resultados preliminares del tratamiento de la seudoartrosis mediante ondas de choque de alta energía: estudio cuasiexperimental multicéntrico
www.sciencedirect.com
December 5, 2025 at 12:48 PM
Efficacy and safety of osilodrostat in patients with ectopic Cushing´s syndrome. a real-world study in Spain link.springer.com/article/10.1... #hvhebron #endo [Text complet]
Efficacy and safety of osilodrostat in patients with ectopic Cushing´s syndrome. a real-world study in Spain - Journal of Endocrinological Investigation
Journal of Endocrinological Investigation - To evaluate the efficacy and safety of osilodrostat in patients with Ectopic Cushing syndrome (ECS). A retrospective, multicenter, real-world study of...
link.springer.com
December 5, 2025 at 12:33 PM
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trial aacrjournals.org/clincancerre... #hvhebron #onco
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trial
Abstract. Purpose: Based on the results from SOLTI-PATRICIA trial (NCT02448420) cohorts A/B, a direct comparison with standard-of-care treatments is needed to evaluate the efficacy and safety of palbo...
aacrjournals.org
December 5, 2025 at 12:32 PM
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial ascopubs.org/doi/10.1200/... #hvhebron #onco
ASCO Publications
ascopubs.org
December 5, 2025 at 12:31 PM
Impact of thrombectomy techniques on outcome in medium or distal vessel occlusion: subanalysis of the DISTAL Trial jnis.bmj.com/content/earl... #hvhebron #neuro [Text complet]
Impact of thrombectomy techniques on outcome in medium or distal vessel occlusion: subanalysis of the DISTAL Trial
Introduction The optimal thrombectomy technique for medium/distal vessel occlusions (MDVOs) remains uncertain. Objective To compare the safety and efficacy of aspiration thrombectomy (ADAPT) versus s...
jnis.bmj.com
December 5, 2025 at 12:29 PM
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study www.nature.com/articles/s41... #hvhebron #hemat
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study - Leukemia
Leukemia - DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study
www.nature.com
December 5, 2025 at 12:28 PM
Mosperafenib, a novel paradox breaker BRAF inhibitor with potent preclinical activity in BRAF mutated colorectal cancer aacrjournals.org/mct/article-... #hvhebron #onco
Mosperafenib, a novel paradox breaker BRAF inhibitor with potent preclinical activity in BRAF mutated colorectal cancer
Abstract. The therapeutic benefit of the combination of the first generation BRAFi encorafenib and the EGFR blocking antibody cetuximab in second line metastatic colorectal cancers (CRC) harboring BRA...
aacrjournals.org
December 5, 2025 at 12:16 PM
Abbreviated or standard antiplatelet therapy after PCI in HBR patients with chronic kidney disease: a prespecified analysis from the MASTER DAPT trial eurointervention.pcronline.com/article/abbr... #hvhebron #cardio
Abbreviated or standard antiplatelet therapy after PCI in HBR patients with chronic kidney disease: prespecified analysis from the MASTER DAPT trial
Study on the comparative effectiveness of abbreviated vs. standard antiplatelet therapy in high bleeding risk patients with and without chronic kidney disease undergoing PCI.
eurointervention.pcronline.com
December 5, 2025 at 12:15 PM
Value of 24- to 48-Hour Infarct Volume as a Surrogate for Clinical Outcome in Late-Window Thrombectomy May be Limited: A Post Hoc Analysis of the AURORA Collaboration www.ahajournals.org/doi/10.1161/... #hvhebron #neuro
Value of 24- to 48-Hour Infarct Volume as a Surrogate for Clinical Outcome in Late-Window Thrombectomy May be Limited: A Post Hoc Analysis of the AURORA Collaboration | Stroke
BACKGROUND: The utility of 24- to 48-hour follow-up infarct volume (FIV) as a surrogate outcome in late time-window acute ischemic stroke is unclear. We aimed to determine associations of 24- to 48-ho...
www.ahajournals.org
December 5, 2025 at 12:14 PM
Inflammatory and Immune Effects of Pollution: Comparison Between Patients With Asthma and Healthy Individuals www.jiaci.org/ahead-of-pri... #hvhebron #pneu
JIACI · Journal of Investigational Allergology and Clinical Immunology
www.jiaci.org
December 5, 2025 at 11:42 AM
4D Flow Cardiovascular Magnetic Resonance Uncovers the Hemodynamic Clue in Aortic Dissection www.sciencedirect.com/science/arti... #hvhebron #cardio #rad #mintens #anest #ccardi #cv [Text complet]
4D Flow Cardiovascular Magnetic Resonance Uncovers the Hemodynamic Clue in Aortic Dissection
Persistent or recurrent aortic coarctation after surgical repair can create hemodynamic stress that predisposes to aneurysm formation and dissection.A…
www.sciencedirect.com
December 5, 2025 at 11:40 AM
Collaborative framework on responsible AI in LLM-driven CDSS for precision oncology leveraging real-world patient data www.nature.com/articles/s41... #hvhebron #onco [Text complet]
Collaborative framework on responsible AI in LLM-driven CDSS for precision oncology leveraging real-world patient data - npj Precision Oncology
npj Precision Oncology - Collaborative framework on responsible AI in LLM-driven CDSS for precision oncology leveraging real-world patient data
www.nature.com
December 5, 2025 at 10:23 AM
Reposted
🔵II Workshop sobre modelos de publicación científica.
🔵12 de diciembre, 10-13h.
Se abordará la publicación científica y la ciencia abierta, modelos alternativos de publicación y evaluación. 
https://www.rebiun.org/eventos/2025/ii-workshop-sobre-modelos-de-publicacion-cientifica
December 5, 2025 at 8:15 AM
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial) www.sciencedirect.com/science/arti... #hvhebron #malinf [Text complet]
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial)
We evaluated the efficacy, safety and impact on viral reservoir of rapid bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) initiation duri…
www.sciencedirect.com
December 4, 2025 at 1:19 PM